JPWO2023182480A5 - - Google Patents
Info
- Publication number
- JPWO2023182480A5 JPWO2023182480A5 JP2024509249A JP2024509249A JPWO2023182480A5 JP WO2023182480 A5 JPWO2023182480 A5 JP WO2023182480A5 JP 2024509249 A JP2024509249 A JP 2024509249A JP 2024509249 A JP2024509249 A JP 2024509249A JP WO2023182480 A5 JPWO2023182480 A5 JP WO2023182480A5
- Authority
- JP
- Japan
- Prior art keywords
- aqueous composition
- composition according
- ester
- come
- container
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022050275 | 2022-03-25 | ||
| PCT/JP2023/011739 WO2023182480A1 (ja) | 2022-03-25 | 2023-03-24 | 水性組成物 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPWO2023182480A1 JPWO2023182480A1 (cg-RX-API-DMAC7.html) | 2023-09-28 |
| JPWO2023182480A5 true JPWO2023182480A5 (cg-RX-API-DMAC7.html) | 2026-01-20 |
Family
ID=88101709
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024509249A Pending JPWO2023182480A1 (cg-RX-API-DMAC7.html) | 2022-03-25 | 2023-03-24 |
Country Status (14)
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2026130361A1 (zh) * | 2024-12-17 | 2026-06-25 | 沈阳兴齐眼药股份有限公司 | 药物组合物、其制备方法及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4806956B2 (ja) * | 2004-04-20 | 2011-11-02 | 大正製薬株式会社 | 点眼用液剤 |
| US20070004805A1 (en) * | 2005-07-01 | 2007-01-04 | Navinta Llc | Process for preparation of liquid dosage form containing sodium 4-phenylbutyrate |
| JP2009078977A (ja) * | 2007-09-25 | 2009-04-16 | Japan Health Science Foundation | 心筋の小胞体ストレス抑制剤 |
| EP2127638A1 (en) * | 2008-05-30 | 2009-12-02 | Santen Pharmaceutical Co., Ltd | Method and composition for treating ocular hypertension and glaucoma |
| US8962686B2 (en) * | 2010-04-28 | 2015-02-24 | The Chinese University Of Hong Kong | Method and medication for prevention and treatment of ocular hypertension and glaucoma |
| EP2698155A1 (en) * | 2012-08-16 | 2014-02-19 | Lunamed AG | Pharmaceutical unit dosage form comprising 4-phenylbutyric acid |
| PT3593817T (pt) | 2017-03-06 | 2024-12-17 | Tsubota Lab Inc | Composição para a utilização na prevenção ou supressão da miopia |
| EP3603642B1 (en) * | 2017-03-27 | 2024-01-10 | Alcon Inc. | Pharmaceutical preparation |
| CN113164421A (zh) | 2018-12-18 | 2021-07-23 | 参天制药株式会社 | 含有4-苯基丁酸的老视的治疗或预防剂 |
| CN111024960B (zh) * | 2019-12-27 | 2023-02-17 | 广州阳普医疗科技股份有限公司 | 用于高血压血样检测的添加剂、试剂盒和应用 |
-
2023
- 2023-03-24 AU AU2023240729A patent/AU2023240729A1/en active Pending
- 2023-03-24 TW TW112111197A patent/TW202400133A/zh unknown
- 2023-03-24 IL IL315871A patent/IL315871A/en unknown
- 2023-03-24 EP EP23775073.2A patent/EP4483867A4/en active Pending
- 2023-03-24 CN CN202380029644.0A patent/CN118973561A/zh active Pending
- 2023-03-24 MX MX2024011634A patent/MX2024011634A/es unknown
- 2023-03-24 KR KR1020247035255A patent/KR20240159636A/ko active Pending
- 2023-03-24 JP JP2024509249A patent/JPWO2023182480A1/ja active Pending
- 2023-03-24 US US18/847,501 patent/US20250213510A1/en active Pending
- 2023-03-24 PE PE2024002054A patent/PE20250746A1/es unknown
- 2023-03-24 WO PCT/JP2023/011739 patent/WO2023182480A1/ja not_active Ceased
- 2023-03-24 CA CA3254664A patent/CA3254664A1/en active Pending
- 2023-03-24 MA MA67594A patent/MA67594B1/fr unknown
-
2024
- 2024-09-23 CL CL2024002831A patent/CL2024002831A1/es unknown